Mirror Biologics, Inc.
Records under this name other than the patents Mirror Biologics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 19 patents it holds.
Back to Mirror Biologics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,785,188 | Method to Formulate T-Cells Lapsed on the fee record Ended Jul 22, 2026 · Medium confidence | Lapsed on the fee record | Ended Jul 22, 2026 | Medium confidence |
| US 8,778,678 | Composition of activated CD4 cells Lapsed on the fee record Ended Jul 15, 2026 · High confidence | Lapsed on the fee record | Ended Jul 15, 2026 | High confidence |
| US 8,883,974 | Device for enhancing immunostimulatory capabilities of T-cells Term ended Term ended Apr 22, 2026 · USPTO record | Term ended | Term ended Apr 22, 2026 | USPTO record |
| US 11,213,576 | Vaccine comprising allogeneic T-cells Lapsed on the fee record Ended Jan 4, 2026 · USPTO record | Lapsed on the fee record | Ended Jan 4, 2026 | USPTO record |
| US 10,548,956 | Allogeneic cellular immunotherapy for opportunistic infection Term ended Ended no later than Oct 14, 2025 · USPTO record | Term ended | Ended no later than Oct 14, 2025 | USPTO record |
| US 7,678,572 | Methods for preparing T-cells for cell therapy Term ended Term ended Aug 25, 2025 · USPTO record | Term ended | Term ended Aug 25, 2025 | USPTO record |
| US 11,045,541 | Allogeneic T-cell compositions for induction of IL-12 Lapsed on the fee record Ended Jun 29, 2025 · USPTO record | Lapsed on the fee record | Ended Jun 29, 2025 | USPTO record |
| US 7,402,431 | T-Cell Therapy Formulation Term ended Term ended Apr 15, 2025 · High confidence | Term ended | Term ended Apr 15, 2025 | High confidence |
| US 7,435,592 | Compositions for Allogeneic Cell Therapy Term ended Term ended Apr 15, 2025 · High confidence | Term ended | Term ended Apr 15, 2025 | High confidence |
| US 9,593,308 | Device for enhancing immunostimulatory capabilities of T-cells Lapsed on the fee record Ended Mar 14, 2025 · USPTO record | Lapsed on the fee record | Ended Mar 14, 2025 | USPTO record |